12例GFAP-IgG阳性患儿重叠综合征的临床特征分析
The Analysis of Clinical Characteristics of Overlapping Syndrome in 12 Children with GFAP-IgG Positive
DOI: 10.12677/ACM.2023.134941, PDF,   
作者: 杨婷婷, 吴 鹏*:重庆医科大学附属儿童医院神经内科,国家儿童健康与疾病临床医学研究中心,儿童发育疾病研究教育部重点实验室,儿科学重庆市重点实验室,重庆
关键词: GFAP-IgG重叠抗体重叠综合征复发GFAP-IgG Overlapping Antibody Overlapping Syndrome Relapse
摘要: 背景:自身免疫性胶质纤维酸性蛋白(GFAP)星形细胞病变是一种自身免疫性中枢神经系统疾病,GFAP-IgG是其特异性抗体,现报道大约有30%~40%患者常与其他抗体共存。目的:探讨儿童自身免疫性GFAP星形细胞病变的重叠抗体临床特征分析。方法:收集2020年1月~2022年12月在重庆医科大学儿童医院住院治疗的43例脑脊液和/或血清GFAP抗体阳性的中枢神经系统疾病患者,回顾性分析其中出现重叠综合征的12例患儿的临床资料。结果:共纳入GFAP-IgG阳性患者43例,其中重叠综合征12例。其中AQP4抗体阳性3例,MOG抗体阳性2例,NMDAR抗体及MOG抗体同时阳性3例,NMDAR抗体阳性1例;抗Sulfatide抗体IgG阳性2例,抗GM1、抗GD1b抗体IgM阳性1例。我们发现重叠抗体患儿有近50%出现复发,尤其以重叠NMDAR抗体和AQP4抗体突出,需联合吗替麦考酚酯等免疫抑制剂治疗。
Abstract: Background: Autoimmune glial fibrillary acidic protein astrocytopathy is an autoimmune central system disease, and GFAP-IgG is specific. It is reported that about 30% to 40% of patients often co-exist with other antibodies. Objective: To investigate the clinical characteristics of overlapping an-tibodies in autoimmune GFAP astrocytopathyin children. Methods: We collected 43 patients with positive GFAP-IgG in cerebrospinal fluid and/or serum, and treated in Children’s Hospital of Chong-qing Medical University from January 2020 to December 2022, and analyzed the clinical data of 12 patients with overlapping syndrome retrospectively. Results: 43 patients with positive GFAP-IgG which were included, of whom 12 were defined as overlapping syndrome. Among them, 3 cases were positive for AQP4 antibody, 2 cases for MOG antibody, 3 cases for both NMDAR antibody and MOG antibody, 1 case for NMDAR antibody, 2 cases for anti-Sulfatide-IgG, and 1 case for anti-GM1 antibody and anti-GD1b antibody. We found that about 50% of pediatric patients with overlapping antibodies relapsed, especially with overlapping NMDAR antibody and AQP4 antibody, which needed to be treated with immunosuppressants such as mycophenolate mofetil.
文章引用:杨婷婷, 吴鹏. 12例GFAP-IgG阳性患儿重叠综合征的临床特征分析[J]. 临床医学进展, 2023, 13(4): 6731-6737. https://doi.org/10.12677/ACM.2023.134941

参考文献

[1] Shan, F., Long, Y. and Qiu, W. (2018) Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Review of the Literature. Frontiers in Immunology, 9, Article ID: 2802. [Google Scholar] [CrossRef] [PubMed]
[2] Martinez-Hernandez, E., Guasp, M., García-Serra, A., et al. (2020) Clinical Significance of Anti-NMDAR Concurrent with Glial or Neuronal Surface Antibodies. Neurology, 94, e2302-e2310. [Google Scholar] [CrossRef
[3] Murakami, K., Miyamoto, K., Hiwatani, Y., Kajimoto, Y. and Ito, H. (202) Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy Overlapping with Immunoglobulin G An-ti-GM1 Antibody-Associated Acute Motor Axonal Neuropathy. Neurological Sciences, 43, 6583-6584. [Google Scholar] [CrossRef] [PubMed]
[4] Berer, K., Mues, M., Koutrolos, M., et al. (2011) Commensal Microbiota and Myelin Autoantigen Cooperate to Trigger Autoimmune Demyelination. Nature, 479, 538-541. [Google Scholar] [CrossRef] [PubMed]
[5] Dalmau, J., Armangué, T., Planagumà, J., et al. (2019) An Update on Anti-NMDA Receptor Encephalitis for Neurologists and Psychiatrists: Mechanisms and Models. The Lancet Neurology, 18, 1045-1057. [Google Scholar] [CrossRef
[6] Fang, B., McKeon, A., Hinson, S.R., et al. (2016) Autoim-mune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. JAMA Neurology, 73, 1297-1307. [Google Scholar] [CrossRef] [PubMed]
[7] Graus, F., Titulaer, M.J., Balu, R., et al. (2016) A Clinical Approach to Diagnosis of Autoimmune Encephalitis. The Lancet Neurology, 15, 391-404. [Google Scholar] [CrossRef
[8] Jarius, S., Paul, F., Aktas, O., et al. (2018) MOG Encepha-lomyelitis: International Recommendations on Diagnosis and Antibody Testing. Journal of Neuroinflammation, 15, Arti-cle No. 134. [Google Scholar] [CrossRef] [PubMed]
[9] Sechi, E., Morris, P.P., McKeon, A., et al. (2019) Glial Fibrillary Acidic Protein IgG Related Myelitis: Characterisation and Comparison with Aquaporin-4-IgG Myelitis. Journal of Neurology, Neurosurgery & Psychiatry, 90, 488-490. [Google Scholar] [CrossRef] [PubMed]
[10] Xu, X., Lu, Q., Huang, Y., et al. (2020) Anti-NMDAR Encephali-tis: A Single-Center, Longitudinal Study in China. Neurology Neuroimmunology & Neuroinflammation, 7, e633. [Google Scholar] [CrossRef